Reduction of Hemolysis in Specimens from Patients in Emergency Departments: Evaluation of Laboratory Medicine Best Practices and Recommendations

The summary for the Reduction of Hemolysis in Specimens from Patients in Emergency Departments: Evaluation of Laboratory Medicine Best Practices and Recommendations grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.
Reduction of Hemolysis in Specimens from Patients in Emergency Departments: Evaluation of Laboratory Medicine Best Practices and Recommendations: Reduction of Hemolysis in Specimens from Patients in Emergency Departments: Evaluation of Laboratory Medicine Best Practices and Recommendations
Federal Grant Title: Reduction of Hemolysis in Specimens from Patients in Emergency Departments: Evaluation of Laboratory Medicine Best Practices and Recommendations
Federal Agency Name: Centers for Disease Control and Prevention
Grant Categories: Health
Type of Opportunity: Continuation
Funding Opportunity Number: CDC-RFA-OE15-150302CONT16
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.064
CFDA Descriptions: Laboratory Training, Evaluation, and Quality Assurance Programs
Current Application Deadline: Apr 15, 2016
Original Application Deadline: Apr 15, 2016
Posted Date: Feb 17, 2016
Creation Date: Feb 17, 2016
Archive Date: May 15, 2016
Total Program Funding:
Maximum Federal Grant Award: $0
Minimum Federal Grant Award: $0
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
This award will be a continuation of funds intended only for grantees previously awarded under CDC-RFA-OE15-1503: Reduction of Hemolysis in Specimens from Patients in Emergency Departments: Evaluation of Laboratory Medicine Best Practices and Recommendations.
Grant Announcement Contact
OGSTIMS Phone 770-488-2700
OGSTIMS

Centers for Disease Control and Prevention 770-488-2756
Similar Government Grants
PPHF 2017: Immunization Grants-CDC Partnership: Strengthening Public Health Laboratories-f...
Improving the Impact of Laboratory Practice: A New Paradigm for Metrics, CSELS and DLPSS
Improving Waived Testing Performance and Outcomes through Partnerships
Use of a Medical Data Warehouse in a Laboratory Quality Improvement Initiative that Links ...
Advance Molecular Detection (AMD)
Improvement of Laboratory Testing and Services in the United States
Initiative to Integrate Clinical Laboratories into Public Health Testing
Developing an Agenda for Laboratory Practice Research Based on the 2007 Institute: Managin...
More Grants from the Centers for Disease Control and Prevention
93.067
Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...
Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...
Strengthening Ebola rapid detection and response capacity through community based surveill...
test2

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com